Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Manufacturing Chemist, 3 May 2023
Presented by the Hénokiens Association and the Château du Clos Lucé
Effective May 1st, 2020
CheManager, 20 October 2020
C&EN, 21 November 2021